CVS vs EBS
CVS Health Corp (CVS) versus Emergent Biosolutions Inc (EBS) — a side-by-side from cached financials, not a winner call.
CVS Health Corp (CVS) is a healthcare plans company listed on US.
Emergent Biosolutions Inc (EBS) is a drug manufacturers - specialty & generic company listed on US.
Latest reported CVS revenue for 2025-12-31 was $402.07B. Net income was $1.77B. Revenue was up 7.8% from 2024-12-31 to 2025-12-31. CVS currently screens at market cap $86.20B and trailing P/E 16.3.
Latest reported EBS revenue for 2024-12-31 was $1.04B. Net income was -$190.6M. Revenue was down 0.5% from 2023-12-31 to 2024-12-31. EBS currently screens at market cap $416.4M.
CVS currently screens at market cap $86.20B and trailing P/E 16.3. EBS currently screens at market cap $416.4M.
Not investment advice. Open the CVS and EBS stock pages for the full models.
Not investment advice.